CRISPR and Genome Editing Technologies
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and genome editing technologies have revolutionized the field of molecular biology by providing precise tools for modifying genetic material. Originally discovered as part of the bacterial immune system, CRISPR has been adapted into a powerful tool for editing genomes in various organisms, including humans. This technology has numerous applications in basic research, biotechnology, and medicine. Consists of CRISPR arrays and Cas proteins (e.g., Cas9, Cas12a). Allows for targeted editing of specific DNA sequences. The process of making precise changes to the DNA of a cell or organism. Besides CRISPR-Cas, other genome editing tools include TALENs (Transcription Activator-Like Effector Nucleases) and ZFNs (Zinc Finger Nucleases). Directs the Cas9 enzyme to the target DNA sequence. Cas9 creates a double-strand break (DSB) at the target site. Corrects mutations responsible for genetic diseases. Disrupts oncogenes or enhances tumor suppressor genes. Modifies stem cells for transplantation and tissue regeneration.Generates animal organs with human-compatible tissues. Developing more precise genome editing tools to minimize off-target effects. Advancing CRISPR-based therapies for a wide range of genetic disorders.
Related Conference of CRISPR and Genome Editing Technologies
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
16th International Conference on Human Genetics and Genetic Diseases
19th International Conference on Genomics & Pharmacogenomics
CRISPR and Genome Editing Technologies Conference Speakers
Recommended Sessions
- Stem Cell Research and Therapy
- Cell and Tissue Engineering
- Bioinformatics and Systems Biology
- Cancer Biology and Cell Signaling
- Cell Cycle and Cell Division
- Cell Migration and Invasion
- Cellular Mechanotransduction
- Cellular Metabolism and Metabolic Disorders
- CRISPR and Genome Editing Technologies
- Developmental Biology and Regenerative Medicine
- Epigenetics and Epigenomics
- Microbiome and Host Interactions
- Molecular and Cellular Immunology
- Molecular Genetics and Gene Therapy
- Molecular Pathology and Diagnostics
- Nanotechnology in Cell Biology
- Neurobiology and Neurodegenerative Diseases
- Proteomics and Protein Engineering
- Signal Transduction and Cell
- Single-Cell Analysis and Applications
- Structural Biology and Molecular Dynamics
- Synthetic Biology and Bioengineering
Related Journals
Are you interested in
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (France)
- Cancer Stem Cells and Oncology - Stemgen 2026 (France)
- Cardiovascular Regeneration - Stemgen 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (France)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (France)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (France)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (France)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (France)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (France)

